Long-term survival and quality of life in patients more than 10 years after pelvic exenteration.

ABSTRACT:

Background

Pelvic exenteration is a curative treatment option for selected patients with advanced primary or recurrent pelvic cancer. This study aimed to evaluate survival and quality-of-life outcomes beyond 10 and up to 17 years following pelvic exenteration.

Method

This longitudinal study included patients who underwent pelvic exenteration between 2008 and 2014. Quality of life was assessed using Short-Form Survey (SF-36v2) and Functional Assessment of Cancer Therapy-Colorectal Cancer (FACT-C) questionnaires at 10 different time points from baseline up to 17 years following pelvic exenteration. Survival data were obtained through registry linkage, with outcomes analysed using Kaplan-Meier methods.

Results

Of the 273 patients included (median age 61.0 years, 59.3% ma

SUBMITTER: Steffens D 

PROVIDER: S-EPMC12159803 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature